相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension
Allan Lawrie et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Reactivation of γHV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin
Edda Spiekerkoetter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Smooth muscle protein 22α-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling
Nesrine El-Bizri et al.
CIRCULATION RESEARCH (2008)
An antiproliferative BMP-2/PPARγ/apoE axis in human and murine SMCs and its role in pulmonary hypertension
Georg Hansmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Pulmonary arterial remodeling induced by a Th2 immune response
Eleen Daley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A USA-based registry for pulmonary arterial hypertension: 1982-2006
T. Thenappan et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension
Fares A. Masri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
The 5-HT transporter transactivates the PDGFβ receptor in pulmonary artery smooth muscle cells
Yinglin Liu et al.
FASEB JOURNAL (2007)
Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac JNK-dependent signaling pathways in colon cancer cells
Clara Grijelmo et al.
CELLULAR SIGNALLING (2007)
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
Sebastien Bonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling
Laimute Taraseviciene-Stewart et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
Alejandro Macchia et al.
AMERICAN HEART JOURNAL (2007)
Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle
Moira Hagen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry
Shen Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
F. Perros et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension - A pilot randomized controlled trial
Xing-Gang Wang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
M. Sean McMurtry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
Joseph T. Crossno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats
Masahiko Oka et al.
CIRCULATION RESEARCH (2007)
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction
Syed R. Baber et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Weiling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Bone morphogenetic protein-2 upregulates expression and function of voltagegated K+ channels in human pulmonary artery smooth muscle cells
Ivana Fantozzi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension
Laurence Dewachter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension
Kaori Ihida-Stansbury et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
HIV-1 nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques
John C. Marecki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1
Xinqi Wu et al.
CIRCULATION RESEARCH (2006)
Reversal of idiopathic pulmonary arterial hypertension and allograft pneumonectomy after single lung transplantation
Subrato Deb et al.
CHEST (2006)
An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats -: Similarities to human pulmonary arterial hypertension
Sébastien Bonnet et al.
CIRCULATION (2006)
Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension
Christophe Guignabert et al.
CIRCULATION RESEARCH (2006)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells -: Role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization
A Cogolludo et al.
CIRCULATION RESEARCH (2006)
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
L Long et al.
CIRCULATION RESEARCH (2006)
Inhibition of vascular smooth muscle cell proliferation in vitro by genetically engineered marrow stromal cells secreting calcitonin gene-related peptide
WW Deng et al.
LIFE SCIENCES (2006)
Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival - Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension
K Teichert-Kuliszewska et al.
CIRCULATION RESEARCH (2006)
Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension
K Ishikura et al.
CIRCULATION JOURNAL (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil
AE Juliana et al.
EUROPEAN JOURNAL OF PEDIATRICS (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension
DB Frank et al.
CIRCULATION RESEARCH (2005)
Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease
A Lawrie et al.
CIRCULATION RESEARCH (2005)
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
RF Machado et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice
YL Song et al.
CIRCULATION (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells
PB Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
CA Dias et al.
ANESTHESIA AND ANALGESIA (2005)
Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension - Twelve-month clinical trial of a single-drug, open-label, pilot study
T Humpl et al.
CIRCULATION (2005)
Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study
MR Wilkins et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Adrenomedullin: angiogenesis and gene therapy
N Nagaya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension
XD Yang et al.
CIRCULATION RESEARCH (2005)
Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor β (PDGFRβ)
Y Takayama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Oral sildenatil improves primary pulmonary hypertension refractory to epoprostenol
M Kataoka et al.
CIRCULATION JOURNAL (2005)
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells - Efficacy of combined cell and eNOS gene therapy in established disease
YDD Zhao et al.
CIRCULATION RESEARCH (2005)
BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways
TK Jeffery et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
5-HT induction of c-fos gene expression requires reactive oxygen species and Rac1 and Ras GTPases
AR Simon et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2005)
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension
A Chaouat et al.
THORAX (2004)
Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle
J West et al.
CIRCULATION RESEARCH (2004)
Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells
NJ Davie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Sitaxsentan therapy for pulmonary arterial hypertension
RJ Barst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension
Y Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
KE Roberts et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia
H Beppu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy
S Greenway et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells - Insights into the association of specific autoantibodies with distinct disease phenotypes
DB Ulanet et al.
ARTHRITIS AND RHEUMATISM (2004)
Extraction of pulmonary vascular compliance, pulmonary vascular resistance, and right ventricular work from single-pressure and Doppler flow measurements in children with pulmonary hypertension: A new method for evaluating reactivity - In vitro and clinical studies
CE Weinberg et al.
CIRCULATION (2004)
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis
MS McMurtry et al.
CIRCULATION RESEARCH (2004)
Overexpression of the 5-hydroxytryptamine transporter gene - Effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension
MR MacLean et al.
CIRCULATION (2004)
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
RE Harrison et al.
JOURNAL OF MEDICAL GENETICS (2003)
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease
S Eddahibi et al.
CIRCULATION (2003)
Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells
T Nishimura et al.
CIRCULATION (2003)
Expression of human herpesvirus 8 in primary pulmonary hypertension
CD Cool et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells
S Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension - A 1-year follow-up study
O Sitbon et al.
CHEST (2003)
Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells
YJ Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
M Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell
Y Arita et al.
CIRCULATION (2002)
Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension
N Rudarakanchana et al.
HUMAN MOLECULAR GENETICS (2002)
Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation - In vitro analysis
MG Frid et al.
CIRCULATION RESEARCH (2002)
CX3C chemokine fractalkine in pulmonary arterial hypertension
K Balabanian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo A Yucatan pig study
CL de Korte et al.
CIRCULATION (2002)
A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model
L Taraseviciene-Stewart et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways
A Nohe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats - Role of increased expression and activity of voltage-gated potassium channels
ED Michelakis et al.
CIRCULATION (2002)
Altered growth responses of muscle cells from patients pulmonary artery smooth with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins
NW Morrell et al.
CIRCULATION (2001)
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats
T Nishimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Hemodynamic unloading leads to regression of pulmonary vascular disease in rats
SB O'Blenes et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
S Eddahibi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
KN Cowan et al.
NATURE MEDICINE (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
分享论文
